Walleye Trading LLC Aerie Pharmaceuticals Inc Transaction History

Walleye Trading LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$4.95 - $9.16 $15,953 - $29,522	-3,223 Reduced 16.86%	15,894 $119,000
Q1 2022 May 16, 2022	BUY	$5.64 - $9.8 $19,779 - $34,368	3,507 Added 22.47%	19,117 $174,000
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $129,252 - $245,431	-18,412 Reduced 54.12%	15,610 $110,000
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $270,604 - $397,540	23,905 Added 236.29%	34,022 $388,000
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $293,089 - $487,740	10,117 New	10,117 $299,000
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $119,295 - $217,044	-3,615 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $202,027 - $265,892	-3,598 Reduced 49.88%	3,615 $223,000
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $343,132 - $505,196	7,171 Added 17073.81%	7,213 $487,000
Q1 2018 May 15, 2018	SELL	$51.15 - $61.0 $716 - $854	-14 Reduced 25.0%	42 $2,000
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $2,847 - $3,645	56	56 $3,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.